Amgen (AMGN)

Download button icon Download

Amgen (AMGN): Signals

No data currently available.


Explore Compare Share


Amgen (AMGN)



Last Signal:


Trading: SELL @ $186.7
Signal Strength: STRONG

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to highlight trends across numerous timeframes. This indicator has the ability to smooth historical results to illustrate trend initiation and status. Although this is a simple trend following indicator & can provide good results when coupled with the right indicator. Note, this indicator does not work well in ranging markets producing unwanted whipsaws and false signals.

Amgen (NASDAQ:AMGN) currently has a confirmed downtrend. Price is currently below the displaced moving average for AMGN Currently, the return on DPO20 is -2.7%.

The Detrended Price Oscillator (DPO) is an indicator designed to remove trend from price and make it easier to identify cycles. DPO does not extend to the last date because it is based on a displaced moving average. However alignment with the most recent is not an issue because DPO is not a momentum oscillator. Instead DPO is used to identify cycle’s highs/lows and estimate cycle length.

Calculation: Detrended Price Oscillator (DPO):
1) Price (X/2 + 1) periods ago minus X-period simple moving average.
Where X is the number of periods;


Stock Exchange: NASDAQ
Company: Amgen
Ticker Codes: | AMGN | NASDAQ:AMGN |

About Amgen (NASDAQ:AMGN):

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Repatha to treat coronary diseases; Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Parsabiv to treat secondary hyperparathyroidism (sHPT); and Aimovig for the prevention of migraine. Its products also comprise Blincyto to treat patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia; Kyprolis, a proteasome inhibitor for the treatment of multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound. The company's marketed products include Neulasta, a pegylated protein to treat cancer patients; Aranesp to treat anemia; Sensipar/Mimpara products to treat sHPT in chronic kidney disease; EPOGEN to treat a lower-than-normal number of red blood cells; NEUPOGEN, a recombinant human granulocyte colony-stimulating factor; and IMLYGIC to treat various cancer cells. It serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. The company has collaborative agreements with Pfizer Inc.; UCB; Bayer HealthCare Pharmaceuticals Inc.; and The University of Texas MD Anderson Cancer Center. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Top 10:

Detrended Price Oscillator

Download button icon Download
Company Close Change (%) Volume Value Signal
MGPI Mgp Ingredients Inc 77.24 -0.7 179,884 -0.03 BEARISH CROSSOVER
FB Facebook Inc 164.34 -1 16,259,377 -0.54 BEARISH CROSSOVER
FORR Forrester Resrch 47.99 -1.2 50,688 -0.22 BEARISH CROSSOVER
MGIC Magic Software 8.45 -1.2 11,371 -0.11 BEARISH CROSSOVER
NCMI National Cinemedia 7.28 -1.4 157,171 -0.07 BEARISH CROSSOVER
PCAR Paccar Inc 67.23 -1.4 1,474,116 -0.54 BEARISH CROSSOVER
EBAY Ebay Inc 36.65 -1.5 8,389,811 -0.05 BEARISH CROSSOVER
CELG Celgene Corp 88.15 -1.7 7,300,155 -0.29 BEARISH CROSSOVER
OTEX Open Text 37.51 -1.7 236,759 -0.1 BEARISH CROSSOVER
MXIM Maxim Integrated 54.21 -1.9 1,311,707 -0.85 BEARISH CROSSOVER
back to top